 |
FDA
Approves SPrandiMet, a Replaglinide and Metformin Fixed-Dose
Combination Tablet for Treatment of Type 2 Diabetes |
| |
Sciele Pharma, Inc. and Novo Nordisk Inc. today
announced that the U.S. Food and Drug Administration approved PrandiMet™ (repaglinide and metformin HCl) tablets, the first and only fixed-dose combination
of the fast-acting secretagogue replaglinide (also known as Prandin®) and insulin sensitizer, metformin, for the treatment of type 2 diabetes (BioSpace) |
| |
|
|
Economic
modelling for vascular checks |
| |
The technical
consultation outlines the modelling work the Department of Health has undertaken in the last
year to establish the clinical and cost effectiveness of the
vascular checks programme. The consultation will be open from
Tuesday until Tuesday 12th August (DoH, UK) |
| |
|
|
FDA
Ponders Requiring Heart Studies for Diabetes Drugs |
| |
The FDA is summoning a panel of experts to consider
whether drug makers should be forced to study the cardiovascular
effects of diabetes drugs (Wall Street Journal, USA) |
| |
|
|
Type
1 diabetes in children still on the rise |
| |
The incidence of new cases of Type 1 diabetes
in children is rising at around 3% a year, according to a report
released today by the (AIHW, Australia) |
| |
|
|
Incidence
of Type 1 diabetes in Australia 2000-2006: first results |
| |
This bulletin presents the latest available
(up to 2006) national data on new cases of Type 1 diabetes for
all ages from Australia's National Diabetes Register (AIHW, Australia) |
| |
|
|
Blood
Glucose Measurement in Patients with Suspected Diabetic Ketoacidosis |
| |
A Comparison of Abbott MediSense PCx Point-of-Care
Meter Values to Reference Laboratory Values (Emergency Nurses Association,
USA) |
| |
|
|
Diabetes
sufferers may soon draw breath to take new treatment |
| |
A treatment being developed by Victorian scientists
involves a drug-delivery technique in which patients use a palm-sized
device to inhale nanosized particles of insulin (The Age, Australia) |
| |
|
|
Neuroendocrine
sleep architecture altered in patients with type 1 diabetes |
| |
When subjectively analyzing the quality of sleep
by mood and symptoms after sleep, the researchers found that type
1 diabetics had less restorative sleep (American Diabetes Association) |
| |
|
